Large language models (LLMs) like ChatGPT and GPT-4 have the potential to assist in clinical practice to automate administrative tasks, draft clinical notes, communicate with patients, and even support clinical decision making. ...
Dec 18, 2023
0
24
A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal ...
Dec 14, 2023
0
2
A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.
Dec 14, 2023
0
4
Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune ...
Dec 13, 2023
0
17
For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone induction and consolidation therapy and with ...
Dec 13, 2023
0
8
The future for AI regulation is currently being charted in the United States and will have significant effects on the health sciences, writes Vanderbilt researcher Laura Stark in a new article.
Dec 13, 2023
0
0
Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase 3 trial has found.
Dec 11, 2023
0
29
For patients with high folate receptor α (FRα)-positive ovarian cancer, a first-in-class antibody-drug conjugate targeting FRα, mirvetuximab soravtansine-gynx (MIRV), shows a significant benefit over chemotherapy, according ...
Dec 7, 2023
0
0
Joe McKown is an avid amateur athlete who has competed in scores of triathlons over the years. Swimming, biking, running, he thrived on challenging feats of endurance.
Dec 7, 2023
0
2
Researchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes.
Dec 6, 2023
0
111
